The Global HIV Vaccine Enterprise organized a half-day workshop that brought together key experts in the field to discuss the knowns and unknowns of what we can learn from various ADCC assays. The meeting reviewed currently available assays, compared methodologies, explored how readouts from different assays can be correlated, and discussed which assays are sufficiently mature to be used to assess immune responses in clinical trials of HIV vaccine candidates. Outcomes of these discussions will be shared with the wider research community.
Date: 28 March, 2017
Steamboat Sheraton Resort
Steamboat Springs, CO
A meeting report to present the meeting outcomes to a larger audience.
Nicole Frahm, Fred Hutchinson Cancer Research Center
George Lewis, University of Maryland
Christiane Moog, University of Strasbourg
Gabriella Scarlatti, Global HIV Vaccine Enterprise
If you have any questions about the meeting, please contact email@example.com